Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Use cases for Economic vs Market Index show when to rely on each signal, aiding risk assessment, timing, and portfolio adjustments.
28,511 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Apple appears to have sealed an early victory in the 2026 chip race, securing dominant access to the most advanced pr...
A 56-year-old chief financial officer debates leaving a high-pressured role for life outside the office, anchored by ...
Marvell Technology’s stock rises to a 25-year high, lifting its S&P 500 position to No. 22. Analysts point to AI-driv...
Long-dated Treasuries extended a six-year losing streak in 2025. A new, low-profile ETF is engineered to profit if ra...
Lawmakers edge toward final action on the ROAD Act, a bill that could reshape how lenders price risk and how quickly ...
Jim Cramer remains wary of Salesforce as growth slows and CIOs shift budgets to less expensive software. He argues th...
CoStar Group confirmed layoffs as it accelerates its AI rollout and strengthens Homes.com. The move comes amid invest...
Bitcoin’s mining difficulty jumped about 15% to roughly 144T, signaling a rapid shift in miner economics. Early on-ch...
Tesla shares slipped as three major developments tug the stock in mixed directions: stricter autonomous driving overs...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
Aging workers and slower inflows of young talent are driving a new 'great mismatch' in the labor market, according to...